Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.36 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CRAT | P43155 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30424012 | 1.00 | SLC22A16 (0.39) | SLC22A16CA4BBOX1CPT2CPT1A | |
| SCHEMBL29426372 | 1.00 | SLC22A16 (0.39) | SLC22A16CA4BBOX1CPT2CPT1A | |
| SCHEMBL29396826 | 0.88 | CA2 (0.41) | SLC22A16CA4BBOX1CPT2CPT1A | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL30300543 | 0.85 | SLC22A16 (0.33) | SLC22A16CA4BBOX1MEN1KMT2A | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL30300542 | 0.85 | SLC22A16 (0.33) | SLC22A16CA4BBOX1MEN1KMT2A | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL30300556 | 0.81 | SLC22A16 (0.35) | SLC22A16CA4BBOX1CPT2CPT1A | |
| SCHEMBL30876948 | 0.81 | SLC22A16 (0.39) | SLC22A16CA4CPT2CPT1A | |
| SCHEMBL34467864 | 0.80 | BBOX1 (0.38) | SLC22A16CA4BBOX1 | |
| SCHEMBL30201053 | 0.79 | CA4 (0.41) | SLC22A16CA4BBOX1CPT2CPT1A | |
| SCHEMBL31046982 | 0.79 | CA4 (0.43) | SLC22A16CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118489060-A | Compositions and methods for diagnosing and treating chronic kidney disease | 雀巢产品有限公司 | 2024-08-13 | — | — | CN | claimed |
| EP-4457514-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | Société des Produits Nestlé S.A. (CH) | 2024-11-06 | — | — | EP | disclosed |
| CN-118489060-A | Compositions and methods for diagnosing and treating chronic kidney disease | 雀巢产品有限公司 | 2024-08-13 | — | — | CN | disclosed |
| WO-2023126759-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | Société des Produits Nestlé S.A. (CH) | 2023-07-06 | — | — | WO | disclosed |
| CN-114981452-A | Biomarkers and their use for diagnosing silent periods of alzheimer's disease | 阿根特公司 | 2022-08-30 | — | — | CN | disclosed |